After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...

Regeneron (NASDAQ: REGN) is testing its drug, trevogrumab, along with Wegovy and another treatment, garetosmab, in a ...

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to Novo Nordisk's Wegovy and Ozempic weight-loss drugs. Hims stock stood ...

Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday ...

People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...

Sales of weight loss drug Wegovy more than doubled in the final ... or by people sending in photos of themselves.

In this article, we will be taking a look at the 10 best weight loss drugs to buy according to analysts.

We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.